Treatment Outcomes for HIV‐Uninfected Patients with Multidrug‐Resistant and Extensively Drug‐Resistant Tuberculosis
Author(s) -
Yong Soo Kwon,
Yee Hyung Kim,
Gee Young Suh,
Kyung Soo Chung,
Hojoong Kim,
O Jung Kwon,
YongSoo Choi,
Kwhanmien Kim,
Young Tae Kim,
Young Mog Shim,
WonJung Koh
Publication year - 2008
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/590005
Subject(s) - medicine , tuberculosis , extensively drug resistant tuberculosis , drug resistance , multiple drug resistance , regimen , culture conversion , univariate analysis , logistic regression , surgery , sputum , multi drug resistant tuberculosis , mycobacterium tuberculosis , multivariate analysis , pathology , microbiology and biotechnology , biology
Multidrug-resistant (MDR) tuberculosis (TB) is more difficult to treat than is drug-susceptible TB. To elucidate the optimal therapy for MDR TB, we assessed the treatment outcomes and prognostic factors for patients with MDR TB.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom